Corporate Tech Investors

Galileo Pharmaceuticals

Galileo Pharmaceuticals is a corporate VC investing group that invests in startup ventures that can advance its organizational interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Galileo Pharmaceuticals, Inc. is a privately held, Santa Clara, California based biotechnology company focused on developing drugs that target redox signalling pathways. The chemical reaction by which a molecule accepts (REDuction) or donates electrons (OXidation), commonly known as Redox, is a fundamental process in cellular energy metabolism. Redox failure occurs when the cell's ability to use and store energy is destroyed, and this condition has been implicated in life-threatening pathologies including ischemia, inflammation and metabolic disease.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

11/21/2005

Transaction History

Our records indicate that Galileo Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Lloyd Kunimoto

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Galileo Pharmaceuticals has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Galaxy Interactive | Gallo Digital

Share this article

About Our Corporate VC Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary